Dicerna Pharmaceuticals, Inc.
(NASDAQ : DRNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.53%91.171.3%$817.16m
AMGNAmgen Inc.
0.99%188.821.2%$646.84m
GILDGilead Sciences, Inc.
0.30%66.960.9%$517.58m
BIIBBiogen Inc.
0.45%334.501.3%$453.56m
ILMNIllumina, Inc.
-0.60%300.463.5%$322.03m
REGNRegeneron Pharmaceuticals, Inc.
-0.32%419.272.6%$309.65m
VRTXVertex Pharmaceuticals Incorporated
0.40%187.611.9%$272.77m
ALXNAlexion Pharmaceuticals, Inc.
0.48%129.552.0%$236.67m
SRPTSarepta Therapeutics, Inc.
1.06%141.7415.4%$159.96m
AAgilent Technologies, Inc.
0.67%78.041.6%$143.35m
EXASExact Sciences Corporation
-2.29%83.6125.3%$127.65m
INCYIncyte Corporation
-0.44%83.712.5%$116.04m
ARRYArray BioPharma Inc.
0.63%23.258.2%$111.19m
EXELExelixis, Inc.
-0.23%21.306.4%$84.32m
NBIXNeurocrine Biosciences, Inc.
-0.25%80.695.1%$82.44m

Company Profile

Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases using its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James C. Jenson and John J. Rossi in 2007 and is headquartered in Watertown, MA.